Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy
- PMID: 25340766
- PMCID: PMC4207829
- DOI: 10.1371/journal.pone.0111400
Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy
Abstract
Combination antiretroviral therapy (cART) has been widely available in Ghana since 2004. The aim of this cohort study was to assess the incidences of death, AIDS-defining events and non-AIDS defining events and associated risk factors amongst patients initiating cART in a large treatment centre. Clinical and laboratory data were extracted from clinic and hospital case notes for patients initiating cART between 2004 and 2010 and clinical events graded according to recognised definitions for AIDS, non-AIDS events (NADE) and death, with additional events not included in such definitions such as malaria also included. The cumulative incidence of events was calculated using Kaplan Meier analysis, and association of risk factors with events by Cox proportional hazards regression. Data were closed for analysis on 31st December, 2011 after a median follow-up of 30 months (range, 0-90 months). Amongst 4,039 patients starting cART at a median CD4 count of 133 cells/mm3, there were 324 (8%) confirmed deaths, with an event rate of 28.83 (95% CI 25.78-32.15) deaths per 1000-person follow-up years; the commonest established causes were pulmonary TB and gastroenteritis. There were 681 AIDS-defining events (60.60 [56.14-65.33] per 1000 person years) with pulmonary TB and chronic diarrhoea being the most frequent causes. Forty-one NADEs were recorded (3.64 [2.61-4.95] per 1000 person years), of which hepatic and cardiovascular events were most common. Other common events recorded outside these definitions included malaria (746 events) and respiratory tract infections (666 events). Overall 24% of patients were lost-to-follow-up. Alongside expected risk factors, stavudine use was associated with AIDS [adjusted HR of 1.08 (0.90-1.30)] and death (adjusted HR of 1.60 [1.21-2.11]). Whilst frequency of AIDS and deaths in this cohort were similar to those described in other sub-Saharan African cohorts, rates of NADEs were lower and far exceeded by events such as malaria and respiratory tract infections.
Conflict of interest statement
Figures
Similar articles
-
Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.AIDS Res Ther. 2020 Jul 17;17(1):44. doi: 10.1186/s12981-020-00300-4. AIDS Res Ther. 2020. PMID: 32680536 Free PMC article.
-
Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.PLoS Med. 2018 Jan 30;15(1):e1002491. doi: 10.1371/journal.pmed.1002491. eCollection 2018 Jan. PLoS Med. 2018. PMID: 29381702 Free PMC article.
-
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.AIDS. 2011 Jul 31;25(12):1471-9. doi: 10.1097/QAD.0b013e328347f9d4. AIDS. 2011. PMID: 21572309 Free PMC article.
-
Competing risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia.BMC Infect Dis. 2024 Dec 18;24(1):1412. doi: 10.1186/s12879-024-10280-9. BMC Infect Dis. 2024. PMID: 39695972 Free PMC article.
-
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Lancet. 2009. PMID: 19361855 Free PMC article. Review.
Cited by
-
Increasing trends of overweight and obesity in treatment-naive people living with HIV in Shenzhen from 2014 to 2020: an emerging health concern.Front Public Health. 2023 Oct 10;11:1186838. doi: 10.3389/fpubh.2023.1186838. eCollection 2023. Front Public Health. 2023. PMID: 37900013 Free PMC article.
-
Coinfection with Hymenolepis nana, Hymenolepis diminuta, Giardia intestinalis, and Human Immunodeficiency Virus: A Case Report with Complex Immunologic Interactions.Am J Trop Med Hyg. 2017 May;96(5):1094-1096. doi: 10.4269/ajtmh.16-0413. Epub 2017 May 13. Am J Trop Med Hyg. 2017. PMID: 28219994 Free PMC article.
-
Risk factors for stroke occurrence in a low HIV endemic West African country: A case-control study.J Neurol Sci. 2018 Dec 15;395:8-16. doi: 10.1016/j.jns.2018.09.021. Epub 2018 Sep 20. J Neurol Sci. 2018. PMID: 30268726 Free PMC article.
-
Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study.eNeurologicalSci. 2019 Apr 5;15:100189. doi: 10.1016/j.ensci.2019.100189. eCollection 2019 Jun. eNeurologicalSci. 2019. PMID: 31011634 Free PMC article.
-
Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.AIDS Res Ther. 2020 Jul 17;17(1):44. doi: 10.1186/s12981-020-00300-4. AIDS Res Ther. 2020. PMID: 32680536 Free PMC article.
References
-
- Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, et al. for the ANRS 1215/1290 Study Group (2005) Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1 infected adults. J Acquir Immune Defic Syndr. 38: 14–17. - PubMed
-
- Desclaux A, Ciss M, Taverne B, Sow PS, Egrot M, et al. (2003) Access to antiretroviral drugs and AIDS management in Senegal. AIDS. 17 (Suppl): S95–S101. - PubMed
-
- Akileswaran C, Lurie MN, Flanigan TP, Mayer KH (2005) Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis. 4: 376–385. - PubMed
-
- Braistein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration; Antiretroviral Therapy Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet ( 367) 817–824. - PubMed
-
- Coetzee D, Hilderbrand K, Boulle A, Maartens G, Louis F, et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 18: 887–895. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials